Comorbidity and risk of cardiac events in patients with acute coronary syndrome

R.R. Komorovsky

References  

  1. Komorovsky RR. Prognostication of the effectiveness of statins for secondary prevention of cardiac events in patients with acute coronary syndrome. Ukr. Cardiol. J. 2008;1:27-32.
  2. Andersen H.R, Nielsen T.T, Rasmussen K. et al, for the DANAMI-2 Investigators. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. New Engl J. Med. 2003;349(8):733-742. doi: 10.1056/NEJMoa025142
  3. Braunwald E, Antman EM, Beasley JW. et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol. 2000;36:970-1062. doi: 10.1016/S0735-1097(00)00889-5.
  4. El Miedany Y. Comorbidity index. In: Comorbidity in rheumatic diseases. Ed. Y. El Miedany. Springer International Publishing AG; 2017:323-344. doi: 10.1007/978-3-319-59962-5.
  5. Ibanez B, James S, Agewall S. et al. for the ESC Scientific Document Group. 2017 Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119-177. doi: 10.1093/eurheartj/ehx393
  6. Komorovsky R, Desideri A, Coscarelli S, Cortigiani L, Celegon L. Impact of carotid arterial narrowing on outcomes of patients with acute coronary syndromes. Am J Cardiol. 2004;93(12):1552-1555. doi: 10.1016/j.amjcard.2004.03.012
  7. Komorovsky R, Desideri A, Coscarelli S. et al. The efficacy of statin therapy in patients with acute coronary syndromes and concomitant carotid disease. Clin Cardiol. 2010;33(2):E15-E19. doi: 10.1002/clc.20610.
  8. Maeder MT. Comorbidities in patients with acute coronary syndrome: a rare and negligible in trials but common and crucial in the real world. Heart. 2014;100(4):268-270. doi: 10.1136/heartjnl-2013-305104.
  9. Palau P, Núñez J, Sanchis J. et al. Differential prognostic effect of revascularization according to a simple comorbidity index in high-risk non-ST-segment elevation acute coronary syndrome. Clin. Cardiol. 2012;35(4):237-243. doi: 10.1002/clc.20996.
  10. Radovanovic D, Seifert B, Urban P. et al. on behalf of the AMIS Plus Investigators. Validity of Charlson comorbidity index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS Plus registry 2002-2012. Heart. 2014;100(4):288-294. doi: 10.1136/heartjnl-2013-304588.
  11. Roffi M, Patrono C, Collet J–P et al for the ESC Scientific Document Group. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur. Heart J. 2016;37(3):267-315. doi: 10.1093/eurheartj/ehv320.
  12. Sanchis J, Núñez J, Bodí V. et al. Influence of comorbid conditions on one-year outcomes in non-ST-segment elevation acute coronary syndrome. Mayo Clin Proc. 2011;86(4):291-296. doi: 10.4065/mcp.2010.0702.
  13. Sanchis J, Ruiz V, Bonanad C. et al. Prognostic value of geriatric conditions beyond age after acute coronary syndrome. Mayo Clin Proc. 2017;92(6):934-939. doi: 10.1016/j.mayocp.2017.01.018.
  14. Schwartz GG, Olsson AG, Ezekowitz MD et al. for the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA. 2011;285(13):1711-1718. doi: 10.1001/jama.285.13.1711.
  15. Thygesen K, Alpert JS, Jaffe AS. et al, for the ESC Scientific Document Group. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2018. doi: 10.1093/eurheartj/ehy462.
  16. Valgimigli M, Bueno H, Byrne RA. et al, for the ESC Scientific Document Group. 2017 ESC Focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: Task Force for of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018;39(3):213-260. doi: 10.1093/eurheartj/ehx419. 
[PDF] [Contents]